These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 19366576)

  • 21. Clinical disease in sheep caused by bluetongue virus serotype 8, and prevention by an inactivated vaccine.
    Moulin V; Noordegraaf CV; Makoschey B; van der Sluijs M; Veronesi E; Darpel K; Mertens PP; de Smit H
    Vaccine; 2012 Mar; 30(12):2228-35. PubMed ID: 22207091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen.
    Stewart M; Dubois E; Sailleau C; Bréard E; Viarouge C; Desprat A; Thiéry R; Zientara S; Roy P
    Vaccine; 2013 Jan; 31(3):553-8. PubMed ID: 23159460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle.
    Hamers C; Galleau S; Chery R; Blanchet M; Besancon L; Cariou C; Werle-Lapostolle B; Hudelet P; Goutebroze S
    Vet Rec; 2009 Sep; 165(13):369-73. PubMed ID: 19783850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental bluetongue virus infection of sheep; effect of previous vaccination: clinical and immunologic studies.
    Mahrt CR; Osburn BI
    Am J Vet Res; 1986 Jun; 47(6):1191-7. PubMed ID: 3014926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nature and duration of protective immunity to bluetongue virus infection.
    Roy P
    Dev Biol (Basel); 2003; 114():169-83. PubMed ID: 14677687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers.
    van der Sluijs MT; Schroer-Joosten DP; Fid-Fourkour A; Vrijenhoek MP; Debyser I; Gregg DA; Dufe DM; Moulin V; Moormann RJ; de Smit AJ
    Vaccine; 2012 Jan; 30(3):647-55. PubMed ID: 22107846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
    Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
    Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of adaptive immune responses and heterologous protection induced by inactivated bluetongue virus vaccines.
    Breard E; Belbis G; Viarouge C; Nomikou K; Haegeman A; De Clercq K; Hudelet P; Hamers C; Moreau F; Lilin T; Durand B; Mertens P; Vitour D; Sailleau C; Zientara S
    Vaccine; 2015 Jan; 33(4):512-8. PubMed ID: 25500308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bluetongue virus: virology, pathogenesis and immunity.
    Schwartz-Cornil I; Mertens PP; Contreras V; Hemati B; Pascale F; Bréard E; Mellor PS; MacLachlan NJ; Zientara S
    Vet Res; 2008; 39(5):46. PubMed ID: 18495078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the minimum protective dose for bluetongue virus serotype 2 and 8 vaccines in sheep.
    Modumo J; Venter EH
    J S Afr Vet Assoc; 2012 Aug; 83(1):17. PubMed ID: 23327131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bluetongue virus without NS3/NS3a expression is not virulent and protects against virulent bluetongue virus challenge.
    Feenstra F; van Gennip RGP; Maris-Veldhuis M; Verheij E; van Rijn PA
    J Gen Virol; 2014 Sep; 95(Pt 9):2019-2029. PubMed ID: 24914064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
    Zulu GB; Venter EH
    J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.
    Gethmann J; Hüttner K; Heyne H; Probst C; Ziller M; Beer M; Hoffmann B; Mettenleiter TC; Conraths FJ
    Vaccine; 2009 Jun; 27(31):4118-26. PubMed ID: 19410620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A one-year follow-up of antibody response in cattle and sheep after vaccination with serotype 8- and serotype 1-inactivated BT vaccines.
    Zanella G; Bréard E; Sailleau C; Zientara S; Viarouge C; Durand B
    Transbound Emerg Dis; 2014 Oct; 61(5):473-6. PubMed ID: 23331382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.
    Barros SC; Cruz B; Luís TM; Ramos F; Fagulha T; Duarte M; Henriques M; Fevereiro M
    Vet Microbiol; 2009 Jun; 137(3-4):252-9. PubMed ID: 19233575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the humoral immune response in adult dairy cattle three years after vaccination with a bluetongue serotype 8 inactivated vaccine.
    Oura CA; Edwards L; Batten CA
    Vaccine; 2012 Jan; 30(2):112-5. PubMed ID: 22067262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and serological response of sheep to serial challenge with different bluetongue virus types.
    Jeggo MH; Gumm ID; Taylor WP
    Res Vet Sci; 1983 Mar; 34(2):205-11. PubMed ID: 6304836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interference of colostral antibodies with response to a Bluetongue serotype 8 inactivated vaccine in lambs born from hyperimmune ewes.
    Leemans J; Hamers C; Chery R; Bibard A; Besancon L; Duboeuf M; Hudelet P; Goutebroze S; Kirschvink N
    Vaccine; 2013 Apr; 31(15):1975-80. PubMed ID: 23422141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep.
    Hunter P; Modumo J
    Onderstepoort J Vet Res; 2001 Dec; 68(4):331-3. PubMed ID: 12026066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of Antibodies against Bluetongue Virus (BTV) in Sheep 5 to 7.5 Years after Vaccination with Inactivated BTV-8 Vaccines.
    Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Moeller B; Bastian M; Ganter M
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31181733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.